NEW YORK (Reuters Health) – Ultrasound-based controlled attenuation parameter (CAP), a noninvasive tool for overview of hepatic steatosis, must be broken-down with caution as a…
NEW YORK (Reuters Health) – Ultrasound-based controlled attenuation parameter (CAP), a noninvasive tool for overview of hepatic steatosis, must be broken-down with caution as a…